MedPath

DELEXARD

Brand Name: DELEXARD

Generic Name: DOBUTAMINE (as hydrochloride)

Active
Registration Number

DRP-8132-01

Dosage Form

Solution For IV Injection

Issuance Date

May 31, 2024

Expiry Date

April 28, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg/mL (250 mg/5 mL)
Packaging5 mL Type I clear and colorless glass ampoule in PVC tray (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Adrenergic Agent
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

DOBUTAMINE (as hydrochloride)Active
Monograph: dobutamine (as hydrochloride)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.